Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015
Mineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials. The efficacy of this drug group in patients with chronic HF with preserved left ventric...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
"Consilium Medicum" Publishing house
2015-09-01
|
| Edice: | Терапевтический архив |
| Témata: | |
| On-line přístup: | https://ter-arkhiv.ru/0040-3660/article/view/31823 |